Graham Capital Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-487,735
| Closed | -$702K | – | 1335 |
|
|
2025
Q1 | $702K | Buy |
487,735
+295,320
| +153% | +$425K | 0.01% | 636 |
|
|
2024
Q4 | $423K | Sell |
192,415
-45,148
| -19% | -$99.3K | 0.01% | 777 |
|
|
2024
Q3 | $392K | Sell |
237,563
-104,327
| -31% | -$172K | 0.01% | 674 |
|
|
2024
Q2 | $759K | Buy |
+341,890
| New | +$759K | 0.02% | 445 |
|
|
2024
Q1 | – | Sell |
-41,733
| Closed | -$125K | – | 1112 |
|
|
2023
Q4 | $125K | Sell |
41,733
-116,014
| -74% | -$347K | ﹤0.01% | 872 |
|
|
2023
Q3 | $155K | Buy |
+157,747
| New | +$155K | ﹤0.01% | 881 |
|
|
2023
Q2 | – | Sell |
-1,031,068
| Closed | -$1.64M | – | 1044 |
|
|
2023
Q1 | $1.64M | Buy |
1,031,068
+409,894
| +66% | +$652K | 0.05% | 308 |
|
|
2022
Q4 | $3.87M | Buy |
+621,174
| New | +$3.87M | 0.12% | 88 |
|